期刊文献+

胱抑素C与心血管疾病关系研究新进展 被引量:7

下载PDF
导出
摘要 胱抑素C是一种碱性非糖化蛋白质,是半胱氨酸蛋白酶抑制剂家族中的重要成员,可通过调节半胱氨酸蛋白酶活性,参与炎症反应,作用于各系统,有着重要的生理、病理意义,近年来,备受临床关注。
出处 《心血管康复医学杂志》 CAS 2013年第2期194-196,共3页 Chinese Journal of Cardiovascular Rehabilitation Medicine
  • 相关文献

参考文献18

  • 1Barka T,van der Noen H. Expression of the cysteine proteinase inhibitor cystatin C gene in rat heart:use of digoxigenin-labeled probes generated by polymerase chain reaction directly for in situ and northern blot hybridizations[J].Journal of Histochemistry and Cytochemistry,1993,(12):1863-1867.
  • 2Bengtsson E,Nilsson J,Jovinge S. Cystatin C and cathepsins in cardiovascular disease[J].Frontiers in Bioscience,2008.5780-5786.
  • 3Sukhova GK,Wang B,Libby P. Cystatin C deficiency increases elastic lamina degradation and aortic dilatation in apolipop rotein E-null mice[J].Circulation Research,2005,(03):368-375.
  • 4Bengtsson E,To F,Hakansson K. Lack of the cysteine protease inhibitor cystatin C promotes atherosclerosis in apolipoprotein E-deficient mice[J].Arteriosclerosis,Thrombosis,and Vascular Biology,2005,(10):2151-2156.
  • 5K(o)ttgen A,Selvin E,Stevens LA. Serum cystatin C in the United States:the Third National Health and Nutrition Examination Survey (NHANES Ⅲ)[J].American Journal of Kidney Diseases,2008,(03):385-394.doi:10.1053/j.ajkd.2007.11.019.
  • 6谷红霞,孙雪峰,傅博,张彬,黄大伟,陈云爽,陈香美.健康成人血清胱抑素C与增龄关系的探讨[J].中国中西医结合肾病杂志,2010,11(4):314-317. 被引量:14
  • 7Stevens LA,Schmid CH,Greene T. Factors other than glomerular filtration rate affect serum cystatin C levels[J].Kidney International,2009,(06):652-660.
  • 8Kestenbaum B,Rudser KD,de Boer IH. Differences in kidney function and incident hypertension:the multi-ethnic study of atherosclerosis[J].Annals of Internal Medicine,2008,(07):501-508.
  • 9Donahue RP,Stranges S,Rejman K. Elevated cystatin C concentration and progression to pre-diabetes:The Western New York Study[J].Diabetes Care,2007,(07):1724-1729.doi:10.2337/dc07-0040.
  • 10林立平,匡霞.早期糖尿病肾病患者血清胱抑素C变化及意义[J].山东医药,2009,49(7):79-79. 被引量:11

二级参考文献32

  • 1谢华,林洪丽,王陆,王静,方明,李龙凯.血清Cystatin C评价慢性肾脏病患者肾小球滤过功能的对照研究[J].中国中西医结合肾病杂志,2006,7(9):514-516. 被引量:21
  • 2孟存良,齐晓勇,谷剑,李树仁,张建清,李英肖,党懿,王天红.冠心病患者高同型半胱氨酸血症与白细胞介素-8相关性研究[J].中华心血管病杂志,2006,34(11):1042-1042. 被引量:7
  • 3马腾,吴继雄,孙昕.血清C-反应蛋白、可溶性CD40配体、基质金属蛋白酶-2水平与冠心病的相关性[J].临床心血管病杂志,2007,23(3):170-173. 被引量:8
  • 4Filler G,Bokenkamp A,Hofmann W,et al.Cystatin C as a marker of GFR history,Indications and future research[J].Clin Biochem,2005,38(1):1-8.
  • 5Sarnak MJ,Katz R,Stehman-Breon CO,et al.Cystatin C concentration as a risk factor for heart failure in older adults.Ann Intern Med,2005,142(7):497-505.
  • 6陈灏珠译.心脏病学[M].第5版.北京:人民卫生出版社,2003.407-411.
  • 7Barka T,van der Noon H.Expression of the cysteine proteinase inhibitor Cystatin C gene in rat heart:use of digoxi-genin-labeled probes generated by polymerase chain reaction directly for in situ and northem blot hybridizations.J Histochem Cytochem,1993,41:1863-1867.
  • 8Bostom AG,Bausserman L,Jacques PF,et al.Cystatin C as a determinant of fasting plasma total homocysteine levels in coronary artery disease patients with normal serum creatinine.Arterioscler Thromb Vasc Biol,1999,19:2241-2244.
  • 9Sc hiffrin EL,Lipman ML,Mann JF.Chronic kidney disease:effects on the cardiovascular system.Circulation,2007,116:85-97.
  • 10Lassus J,Harjola VP,Sund R,et al.Prognostic value of cystatin C in acute heart failure in relation to other markers of renal function and NT-proBNP.Eur Heart J,2007,28(15):1841-1847.

共引文献107

同被引文献66

  • 1Giuseppe Barbaro.Heart and HAART:Two sides of the coin for HIV-associated cardiology issues[J].World Journal of Cardiology,2010,2(3):53-57. 被引量:1
  • 2杨帆,谭红梅,王虹.血浆同型半胱氨酸水平升高与动脉粥样硬化(英文)[J].生理学报,2005,57(2):103-114. 被引量:60
  • 3唐荣(译),凌云(译),卢洪洲(审校).HIV/AIDS合并慢性肾病者的治疗指南(美国感染病学会推荐方案)——HIV相关肾病的筛选[J].中国艾滋病性病,2006,12(6):585-587. 被引量:10
  • 4Doganer YC,Aydogan U,Aydogdu A,et al.Relationship of cystatin C with coronary artery disease and its severity[J].Coron Artery Dis,2013,24(2):119-126.
  • 5Kiyosue A,Hirata Y,Ando J,et al.Plasma cystatin C concen- tration reflects the severity of coronary artery disease in patients without chronic kidney disease[J].Circ J,2010,74(11):2441-2447.
  • 6Gravning J,Smedsrud MK,Omland T,et al.Sensitive tropo- nin assays and N-terminal pro-B-type natriuretic peptide in acute coronary syndrome:prediction of significant coronary le- sions and long-term prognosis[J].Am Heart J,2013,165(5):716-724.
  • 7Jernberg T,Lindahl B,James S,et al.Cystatin C:a novel predictor of outcome in suspected or confirmed non-ST-ele- vation acute coronary syndmme[J].Circulation,2004,110(16):2342-2348.
  • 8Akerblom A,Wallentin L,Siegbahn A,et al.Cystatin C and esti- mated glomerular filtration rate as predictors for adverse outcome in patients with ST-elevation and non-ST-elevation acute coronary syndromes;results from the platelet Inhibition and Patient Outcomes study[J].Clin Chem,2012,58(1):190-199.
  • 9Ristiniemi N,Lund J,Tertti R,et al.Cystatin C as a predic- tor of all-cause mortality and myocardial infarction in patients with non-ST-elevation acute coronary syndrome[J].Clin Biochem,2012,45(7-8):535-540.
  • 10Cheng XW,Huang Z,Kuzuya M,et al.Cysteine protease ca- thepsins in atherosclerosis-based vascular disease and its com- plications[J].Hypertension,2011,58(6):978-986.

引证文献7

二级引证文献92

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部